Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.87 USD | -5.44% | -25.39% | +88.71% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.71% | 565M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.56% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Y-mAbs Therapeutics Q3 Net Loss Narrows, Revenue Rises